Hematology NewsNovartis nabs first CAR T approval in CanadaSeptember 7, 2018ALLAggressive LymphomasImmunotherapyFollicular LymphomaB Cell Lymphoma
Hematology TimesFirst CAR T-cell therapy approved in CanadaSeptember 7, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsPharmacyALLAggressive LymphomasFollicular Lymphoma
Hematology NewsEngland green-lights coverage of one CAR T-cell therapySeptember 6, 2018Business of MedicinePractice ManagementImmunotherapyALLCellular TherapyAggressive LymphomasB Cell Lymphoma
Hematology TimesCAR T-cell therapy will soon be available in England, NHS saysSeptember 6, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLB Cell Lymphoma
Hematology NewsAdverse events outweigh promise of SGN-CD70A against NHLAugust 30, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesPredicting early outcomes in DLBCLAugust 30, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsNew BTK inhibitor under review in ChinaAugust 29, 2018Mantle Cell LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesNICE says CAR T-cell therapy isn’t cost-effectiveAugust 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsEuropean Commission approves first CAR T-cell therapiesAugust 28, 2018ALLPediatricsLeukemia, Myelodysplasia, TransplantationAggressive LymphomasImmunotherapyB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for DLBCL, PMBCLAugust 28, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology NewsctDNA predicts early outcomes in DLBCLAugust 27, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesEC approves CAR T-cell therapy for ALL, DLBCLAugust 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyALLNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesFDA approves new use for ibrutinib in WMAugust 27, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesSignal strength tied to potency of CAR T-cell therapyAugust 22, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Oncology PracticeSignal strength may limit potency of CAR T-cell therapyAugust 21, 2018Immuno-oncologyCellular TherapyB Cell Lymphoma
